<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02635412</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-16-0085</org_study_id>
    <nct_id>NCT02635412</nct_id>
  </id_info>
  <brief_title>Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial</brief_title>
  <acronym>MAP</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial to investigate the optimal timing of delivery in
      clinically stable women with a suspected morbidly adherent placenta.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled trial to investigate the optimal timing of delivery in
      clinically stable women with a suspected morbidly adherent placenta dispositioned for a
      scheduled delivery. The primary outcome will be assessed by comparing the composite neonatal
      morbidity and composite maternal morbidity between the two groups (delivery at 34 versus 36
      weeks gestational age).
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Never approved by the IRB
  </why_stopped>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite neonatal morbidity</measure>
    <time_frame>Within 72 hours of newborn discharge</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal neonatal morbidity</measure>
    <time_frame>Within 72 hours of patient discharge</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Morbidly Adherent Placenta</condition>
  <condition>Placenta Accreta</condition>
  <arm_group>
    <arm_group_label>Scheduled delivery at 34 weeks</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Scheduled delivery at 34 weeks (range 33 weeks 5 days to 34 weeks 3 days)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scheduled delivery at 36 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scheduled delivery at 36 weeks (range 35 weeks 5 days to 36 weeks 3 days)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Scheduled timing of delivery</intervention_name>
    <arm_group_label>Scheduled delivery at 34 weeks</arm_group_label>
    <arm_group_label>Scheduled delivery at 36 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with monographically morbidly adherent placenta with or without a placenta
             previa.

          -  Scheduled delivery via cesarean hysterectomy

        Exclusion Criteria:

          -  Delivery planned prior to 36 weeks (e.g. non-reassuring fetal status, preterm labor,
             severe preeclampsia, other medical/fetal indication for delivery as determined by the
             managing physician).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>December 16, 2015</study_first_submitted>
  <study_first_submitted_qc>December 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2015</study_first_posted>
  <last_update_submitted>July 3, 2018</last_update_submitted>
  <last_update_submitted_qc>July 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Placenta</keyword>
  <keyword>Accreta</keyword>
  <keyword>Morbidly</keyword>
  <keyword>Adherent Placenta</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

